BPC
UTHR icon

Banque Pictet & Cie’s United Therapeutics UTHR Stock Holding History

Banque Pictet & Cie’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.69M Sell
4,531
-97
-2% -$48.3K 0.02% 195
2025
Q4 		$2.25M Sell
4,628
-150
-3% -$69.9K 0.01% 204
2025
Q3 		$2M Buy
+4,778
New +$1.61M 0.01% 218

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Banque Pictet & Cie's UTHR Position: Q1 2026 in Review

Banque Pictet & Cie reduced its United Therapeutics (UTHR) stake by 2.1% in Q1 2026, selling an estimated $48.3K and leaving 4,531 shares worth $2.69M. The position accounts for 0.02% of the portfolio, ranked #195.

Banque Pictet & Cie first reported a position in UTHR in Q3 2025 and has held it in 3 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Banque Pictet & Cie held 4,531 shares of United Therapeutics worth $2.69M as of Q1 2026.
  • Banque Pictet & Cie sold 97 United Therapeutics shares in Q1 2026, an estimated $48.3K.
  • United Therapeutics made up 0.02% of Banque Pictet & Cie's portfolio in Q1 2026, its #195 holding.
  • Banque Pictet & Cie first reported a position in United Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.